# How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women

> **NCT01801475** · PHASE1,PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 100 (actual)

## Conditions studied

- Postoperative Nausea

## Interventions

- **DRUG:** Ondansetron

## Key facts

- **NCT ID:** NCT01801475
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2015-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01801475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01801475, "How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01801475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*